Zurich Cantonal Bank
TYRA icon

Zurich Cantonal Bank’s Tyra Biosciences TYRA Stock Holding History

Zurich Cantonal Bank’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
8,523
+485
+6% +$16K ﹤0.01% 2223
2026
Q1 		$308K Buy
+8,038
New +$260K ﹤0.01% 2081
2025
Q2 		– Sell
-9,047
Closed -$84.1K – 2630
2025
Q1 		$84.1K Buy
+9,047
New +$117K ﹤0.01% 2440

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Zurich Cantonal Bank's TYRA Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Tyra Biosciences (TYRA) stake by 6% in Q2 2026, buying an estimated $16K and bringing the position to 8,523 shares worth $272K. The position accounts for ﹤0.01% of the portfolio, ranked #2223.

Zurich Cantonal Bank first reported a position in TYRA in Q1 2025 and has held it in 3 quarters since. The position peaked at $308K in Q1 2026. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Zurich Cantonal Bank held 8,523 shares of Tyra Biosciences worth $272K as of Q2 2026.
  • Zurich Cantonal Bank bought 485 Tyra Biosciences shares in Q2 2026, an estimated $16K.
  • Tyra Biosciences made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2223 holding.
  • Zurich Cantonal Bank first reported a position in Tyra Biosciences in Q1 2025 and has held it in 3 quarters since.
  • Zurich Cantonal Bank's Tyra Biosciences position peaked at $308K in Q1 2026.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.